Skip to main content
OpenTrials
Completed

NCT Number: NCT05674435

Clinical Utility of Neuromodulation on Tinnitus

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

Hsinchu, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Tinnitus patients
  • At least one of the neurofeedback methods
  • Single and multi-center
  • Randomized control trials and observational studies

Exclusion criteria

  • Non-peer-reviewed papers, letters, editorials
  • Not English language

Treatment and study plan

Primary outcomes

  1. Tinnitus severity scores

    Time frame: 9 months

Sponsors and collaborators

Lead sponsor

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

Other

Registry information

Official study title

Clinical Utility of Neuromodulation on Tinnitus: A Systematic Review

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 6, 2023
Registry last updated
Jan 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.